Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Melanoma of the Skin (Late Stage^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Name
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 3.1 (3.1, 3.1) N/A 11,419 13.7
Wyoming 6 *** 3.7 (3.1, 4.5) 8 (1, 41) 24 15.0
Wisconsin 6 *** 3.3 (3.1, 3.5) 23 (12, 33) 225 13.6
West Virginia 6 *** 3.6 (3.2, 4.0) 12 (3, 30) 85 16.5
Washington 5 *** 3.1 (2.9, 3.2) 29 (18, 40) 251 11.8
Virginia 6 *** 2.8 (2.7, 3.0) 39 (27, 43) 269 13.9
Vermont 6 *** 4.0 (3.3, 4.7) 5 (1, 32) 31 10.2
Utah 3 *** 4.5 (4.2, 4.9) 1 (1, 6) 121 11.1
Texas 6 *** 2.8 (2.7, 2.9) 40 (31, 43) 778 21.2
Tennessee 6 *** 3.3 (3.1, 3.5) 20 (11, 31) 257 16.4
South Dakota 6 *** 3.0 (2.5, 3.6) 30 (7, 48) 30 11.4
South Carolina 6 *** 2.8 (2.7, 3.1) 38 (25, 45) 169 12.0
Rhode Island 6 *** 3.5 (3.1, 4.0) 14 (2, 38) 45 14.7
Puerto Rico 6 *** 0.5 (0.4, 0.6) N/A 22 15.3
Pennsylvania 6 *** 3.5 (3.3, 3.6) 15 (8, 22) 560 14.9
Oregon 6 *** 2.9 (2.7, 3.1) 36 (22, 44) 140 10.9
Oklahoma 6 *** 3.3 (3.0, 3.5) 22 (9, 35) 143 14.6
Ohio 6 *** 3.6 (3.5, 3.8) 11 (5, 18) 497 14.6
North Dakota 6 *** 3.3 (2.7, 3.9) 21 (3, 46) 26 14.0
North Carolina 6 *** 3.1 (3.0, 3.3) 27 (18, 37) 361 11.9
New York 3 *** 2.5 (2.4, 2.6) 46 (42, 49) 578 13.8
New Mexico 3 *** 2.4 (2.1, 2.7) 47 (37, 50) 60 14.6
New Jersey 3 *** 2.6 (2.5, 2.8) 43 (37, 47) 286 12.2
New Hampshire 6 *** 3.9 (3.5, 4.4) 6 (1, 23) 63 11.6
Nevada 6 *** 2.8 (2.5, 3.1) 41 (20, 47) 73 15.9
Nebraska 6 *** 3.6 (3.3, 4.0) 10 (2, 28) 77 13.3
Montana 6 *** 3.4 (3.0, 3.9) 17 (2, 42) 44 12.4
Missouri 6 *** 3.3 (3.1, 3.5) 24 (12, 33) 231 17.0
Mississippi 6 *** 2.9 (2.7, 3.2) 35 (18, 44) 98 16.3
Minnesota 6 *** 3.3 (3.1, 3.6) 19 (9, 31) 210 10.1
Michigan 5 *** 3.2 (3.0, 3.3) 25 (16, 35) 373 15.5
Maryland 6 *** 2.5 (2.3, 2.6) 45 (41, 49) 169 10.2
Maine 6 *** 3.4 (3.0, 3.9) 18 (4, 39) 61 12.6
Louisiana 3 *** 2.5 (2.3, 2.7) 44 (40, 49) 126 13.6
Kentucky 3 *** 4.0 (3.8, 4.3) 4 (1, 11) 205 14.4
Kansas 6 *** 3.2 (2.9, 3.5) 26 (11, 41) 103 11.8
Iowa 3 *** 4.0 (3.7, 4.3) 3 (1, 14) 145 14.4
Indiana 6 *** 3.9 (3.7, 4.1) 7 (2, 13) 289 17.3
Illinois 6 *** 3.0 (2.9, 3.1) 32 (23, 41) 435 14.1
Idaho 3 *** 3.6 (3.2, 4.0) 13 (2, 32) 68 12.8
Hawaii 3 *** 2.2 (1.9, 2.5) 49 (42, 50) 40 9.8
Georgia 3 *** 3.1 (2.9, 3.2) 28 (19, 38) 331 11.3
Florida 6 *** 3.4 (3.3, 3.6) 16 (10, 23) 951 13.4
District of Columbia 6 *** 1.7 (1.3, 2.2) 50 (46, 50) 11 16.3
Delaware 6 *** 4.2 (3.7, 4.8) 2 (1, 18) 49 13.9
Connecticut 3 *** 2.7 (2.5, 2.9) 42 (29, 48) 121 13.6
Colorado 6 *** 3.7 (3.4, 3.9) 9 (4, 21) 216 16.5
California 3 *** 2.9 (2.8, 3.0) 37 (30, 42) 1,224 12.5
Arkansas 6 *** 2.9 (2.7, 3.2) 34 (19, 44) 103 13.1
Arizona 6 *** 3.0 (2.8, 3.2) 31 (21, 42) 245 11.1
Alaska 6 *** 2.3 (1.8, 2.9) 48 (23, 50) 15 15.2
Alabama 6 *** 3.0 (2.8, 3.2) 33 (20, 43) 169 13.2
Massachusetts 3 ***
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 05/27/2022 12:43 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
3 Source: SEER November 2020 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2020 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top